Enanta Pharmaceuticals (ENTA) Earnings Date & Reports

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ENTA is expected to report earnings to fall 3.78% to -64 cents per share on November 23

Enanta Pharmaceuticals ENTA Stock Earnings Reports

Q3'26

Est.

$-0.64

Q2'26

Missed

by $0.17

Q1'26

Beat

by $0.12

Q4'25

Beat

by $0.39

Q3'25

Beat

by $0.14

The last earnings report on August 10 showed earnings per share of -67 cents, missing the estimate of -50 cents. With 78.88K shares outstanding, the current market capitalization sits at 355.33M.

View a ticker or compare two or three

ENTA

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for ENTA